Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease (Q43529312)

24 November 2017

Identification of a urine metabolomic signature in patients with advanced-stage chronic kidney disease (English)

1 reference

24 November 2017

Maria Posada-Ayala

1

0 references

Fernando De la Cuesta

Fernando de la Cuesta

8

0 references

María G Barderas

Maria G Barderas

10

0 references

Gloria Alvarez-Llamas

Gloria Alvarez-Llamas

13

0 references

Alberto Ortiz

Alberto Ortiz

11

0 references

author name string

Irene Zubiri

2

1 reference

24 November 2017

Marta Martin-Lorenzo

3

1 reference

24 November 2017

Aroa Sanz-Maroto

4

1 reference

24 November 2017

Dolores Molero

5

1 reference

24 November 2017

Laura Gonzalez-Calero

6

1 reference

24 November 2017

Beatriz Fernandez-Fernandez

7

1 reference

24 November 2017

Carlos M Laborde

9

1 reference

24 November 2017

Fernando Vivanco

12

1 reference

24 November 2017

language of work or name

English

0 references

publication date

18 September 2013

1 reference

24 November 2017

1 reference

24 November 2017

85

1 reference

24 November 2017

103-111

1 reference

24 November 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.2013.328

24 November 2017

0 references

cites work

Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Biomarkers in chronic kidney disease: a review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Application of proteomic analysis to the study of renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Metabolomics in the study of kidney diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Plasma metabolomic profiles in different stages of CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Urinary metabolomic analysis for the identification of renal injury in patients with acute heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Selected reaction monitoring for quantitative proteomics: a tutorial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Proteomics meets the scientific method.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Regulation of glutathione synthesis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Role of glutamine in human carbohydrate metabolism in kidney and other tissues

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Phenylacetylglutamine May Replace Urea as a Vehicle for Waste Nitrogen Excretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Accumulation of taurine in patients with renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Sulphur amino acids in plasma and muscle in patients with chronic renal failure: evidence for taurine depletion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Amelioration of metabolic acidosis in patients with low GFR reduced kidney endothelin production and kidney injury, and better preserved GFR.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Human urine as test material in 1H NMR-based metabonomics: recommendations for sample preparation and storage

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.328

7 January 2021

Identifiers

DOI

10.1038/KI.2013.328

1 reference

24 November 2017

1 reference